Bortiad 2 mg Injection
  1. Home
  2. Pharma Products
  3. Adley formulatins
  4. Bortiad 2 mg Injection

Bortiad 2 mg Injection

Bortiad 2 mg Injection contains bortezomib, an anticancer medicine used to treat certain blood cancers. It is supplied as a 2 mg injection and is administered by a healthcare professional through intravenous or subcutaneous injection. It is mainly used in the treatment of multiple myeloma and mantle cell lymphoma.

BUY NOW

Category

Bortezomib is a proteasome inhibitor that interferes with protein breakdown inside cancer cells, helping to stop their growth and survival. Bortiad may be used alone or with other anticancer medicines according to the prescribed treatment regimen. Treatment is generally given in planned cycles, with the dose and schedule determined by the treating oncologist. Regular blood tests and clinical monitoring are important during therapy to assess treatment response and manage potential adverse effects.

Technical Specification

Specification Details
Active Ingredient Bortezomib
Strength 2 mg
Dosage Form Injection
Route of Administration Intravenous or Subcutaneous
Pack Size 1 Vial
Manufacturer/Marketer Adley Pharmaceuticals Ltd

Product Also Known As

Bortiad 2 mg Injection, Bortezomib 2 mg Injection, Bortiad Cancer Injection, Bortezomib Anticancer Injection, Bortiad Multiple Myeloma Injection, Bortezomib Proteasome Inhibitor Injection